Page 146 - 南京医科大学学报自然科学版
P. 146

第42卷第7期
               ·1042 ·                           南 京    医 科 大 学 学         报                        2022年7月


                   e0166901                                     [44] KEIICHIRO S,BOB M,YASUKO D,et al. Aberrant ex⁃
             [32] XIAO X,PUTATUNDA R,ZHANG Y G,et al. Lympho⁃        pansion of segmented filamentous bacteria in IgA ⁃ defi⁃
                   toxin β receptor⁃mediated NFκB signaling promotes glial  cient gut[J]. Proc Natl Acad Sci U S A,2004,101(7):
                   lineage differentiation and inhibits neuronal lineage dif⁃  1981-1986
                   ferentiation in mouse brain neural stem/progenitor cells  [45] GRANDOCH M,FELDMANN K,GÖTHERT J R,et al.
                  [J]. J Neuroinflammation,2018,15(1):49             Deficiency in lymphotoxin β receptor protects from ath⁃
             [33] RIFFELMACHER T,GILES D A,ZAHNER S,et al. Met⁃      erosclerosis in apoE⁃deficient mice[J]. Circ Res,2015,
                   abolic activation and colitis pathogenesis is prevented by  116(8):e57-e68
                   lymphotoxin β receptor expression in neutrophils[J]. Mu⁃  [46] HU D,MOHANTA S K,YIN C J,et al. Artery tertiary
                   cosal Immunol,2021,14(3):679-690                  lymphoid organs control aorta immunity and protect
             [34] GALAL G,TAMMAM H,ABDEL AAL A,et al. Role of        against atherosclerosis via vascular smooth muscle cell
                   lymphotoxin⁃α gene polymorphism in hepatitis C virus⁃re⁃  lymphotoxin β receptors[J]. Immunity,2015,42(6):
                   lated chronic liver disorders[J]. Infect Drug Resist,  1100-1115
                   2021,14:1921-1930                            [47] GUBERNATOROVA E O,POLINOVA A I,PETROPAV⁃
             [35] SELEZNIK G,SEEGER H,BAUER J,et al. The lympho⁃     LOVSKIY M M,et al. Dual role of TNF and LTα in carci⁃
                   toxin β receptor is a potential therapeutic target in renal  nogenesis as implicated by studies in mice[J]. Cancers
                   inflammation[J]. Kidney Int,2016,89(1):113-126   (Basel). 2021,13(8):1775
             [36] HANS L. Pathogenic mechanisms associated with differ⁃  [48] TANIGUCHI K,KARIN M. NF⁃κB,inflammation,immu⁃
                   ent clinical courses of multiple sclerosis[J]. Front Immu⁃  nity and cancer:coming of age[J]. Nat Rev Immunol,
                   nol,2018,9:3116                                   2018,18(5):309-324
             [37] CREUS K K,DE PAEPE B,WEIS J,et al. The multifaceted  [49] ZHOU P H,FANG X F,MCNALLY B A,et al. Targeting
                   character of lymphotoxin β in inflammatory myopathies  lymphotoxin⁃mediated negative selection to prevent pros⁃
                   and muscular dystrophies[J]. Neuromuscul Disord,2012,  tate cancer in mice with genetic predisposition[J]. Proc

                   22(8):712-719                                     Natl Acad Sci U S A,2009,106(40):17134-17139
             [38] Friedrich S K,LANG P A,FRIEBUS⁃KARDASH J,et al.  [50] TANG H D,WANG Y,CHLEWICKI L K,et al. Facilitat⁃
                   Mechanisms of lymphatic system⁃specific viral replication  ing T cell infiltration in tumor microenvironment over⁃
                   and its potential role in autoimmune disease[J]. Clin Exp  comes resistance to PD ⁃ L1 blockade[J]. Cancer Cell,
                   Immunol,2019,195(1):64-73                         2016,29(3):285-296
             [39] ZHU Q Q,LI N,LI F,et al. Association of LTBR polymor⁃  [51] AOYAMA S,NAKAGAWA R,NEMOTO S,et al. Check⁃
                   phisms with chronic hepatitis B virus infection and hepati⁃  point blockade accelerates a novel switch from an NKT⁃
                   tis B virus⁃related hepatocellular carcinoma[J]. Int Immu⁃  driven TNFα response toward a T cell driven IFN⁃γ re⁃
                   nopharmacol,2017,49:126-131                       sponse within the tumor microenvironment[J]. J Immuno⁃
             [40] GATUMU M K,SKARSTEIN K,PAPANDILE A,et al.          ther Cancer,2021,9(6):e002269
                   Blockade of lymphotoxin⁃beta receptor signaling reduces  [52] KANG W,FENG Z C,LUO J W,et al. Tertiary lymphoid
                   aspects of Sjögren’s syndrome in salivary glands of non⁃  structures in cancer:the double⁃edged sword role in anti⁃
                   obese diabetic mice[J]. Arthritis Res Ther,2009,11(1):  tumor immunity and potential therapeutic induction strat⁃
                   R24                                               egies[J]. Front Immunol,2021,12:689270
             [41] DA SILVA ANTUNES R,MEHTA A K,MADGE L,et al.   [53] GAO J J,SHI L Z,ZHAO H,et al. Loss of IFN⁃γ pathway
                   TNFSF14(LIGHT) exhibits inflammatory activities in  genes in tumor cells as a mechanism of resistance to anti-
                   lung fibroblasts complementary to IL⁃13 and TGF⁃β[J].  CTLA⁃4 therapy[J]. Cell,2016,167(2):397-404
                   Front Immunol,2018,9:576                     [54] DE TREZ C. Lymphotoxin⁃beta receptor expression and
             [42] HERRO R,DA SILVA ANTUNES R,AGUILERA A R,et         its related signaling pathways govern dendritic cell ho⁃
                   al. Tumor necrosis factor superfamily 14(LIGHT)controls  meostasis and function[J]. Immunobiology,2012,217
                   thymic stromal lymphopoietin to drive pulmonary fibrosis  (12):1250-1258
                  [J]. J Allergy Clin Immunol,2015,136(3):757-768  [55] ANNA J P,RUTH G. Therapeutic induction of tertiary
             [43] MIKAMI Y,MATSUZAKI H,HORIE M,et al. Lympho⁃        lymphoid structures in cancer through stromal remodeling
                   toxin β receptor signaling induces IL⁃8 production in hu⁃  [J]. Front Immunol,2021,12:674375
                   man bronchial epithelial cells[J]. PLoS One,2014,9                     [收稿日期] 2021-09-28
                  (12):e114791                                                                 (责任编辑:蒋      莉)
   141   142   143   144   145   146   147   148   149   150   151